Clinical Phenotypes of Patients With Systemic Sclerosis With Distinct Molecular Signatures in Skin
Arthritis Care & Research · 2023-07 · 75 (7) · 1469-1480
DOI: 10.1002/acr.24998 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Arthritis Care & Research, online erschienen am 13.03.2023. Verfasst von Monica Yang und 14 weiteren Autor:innen. Beteiligte Einrichtung: University of California San Francisco, San Francisco. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Lung Diseases, Interstitial. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NCATS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Objective
Systemic sclerosis (SSc) patients are classified according to degree of skin fibrosis (limited and diffuse cutaneous [lc and dc]) and serum autoantibodies. We undertook the present multicenter study to determine whether intrinsic subset (IS) classification based upon skin gene expression yields additional valuable clinical information.
Methods
SSc patients and healthy participants (HPs) were classified into Normal‐like, Limited, Fibroproliferative, and Inflammatory ISs using a previously trained classifier. Clinical data were obtained (serum autoantibodies, pulmonary function testing, modified Rodnan skin thickness scores [mRSS], and high‐resolution chest computed tomography [HRCT]). Statistical analyses were performed to compare patients classified by IS, traditional cutaneous classification, and serum autoantibodies.
Results
A total of 223 participants (165 SSc [115 dcSSc and 50 lcSSc] and 58 HPs) were classified. Inflammatory IS patients had higher mRSS (22.1 ± 9.9; P < 0.001) than other ISs and dcSSc patients (19.4 ± 9.4; P = 0.05) despite similar disease duration (median [interquartile range] months 14.9 [19.9] vs. 18.4 [31.6]; P = 0.48). In multivariable modeling, no significant association between mRSS and RNA polymerase III ( P = 0.07) or anti–topoisomerase I (Scl‐70) ( P = 0.09) was found. Radiographic interstitial lung disease (ILD) was more prevalent in Fibroproliferative IS compared with other ISs (91%; P = 0.04) with similar prevalence between lcSSc and dcSSc (67% vs. 76%; P = 0.73). Positive Scl‐70 antibody was the strongest ILD predictor ( P < 0.001). Interestingly, all lcSSc/Fibroproliferative patients demonstrated radiographic ILD.
Conclusions
Classification by IS identifies patients with distinct clinical phenotypes versus traditional cutaneous or autoantibody classification. IS classification identifies subgroups of SSc patients with more radiographic ILD (Fibroproliferative), higher mRSS (Inflammatory), and milder phenotype (Normal‐like) and may provide additional clinically useful information to current SSc classification systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of California San Francisco, San Francisco.
- Northwestern University Feinberg School of Medicine, Chicago, Illinois.
- Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
- Stanford University, Palo Alto, California.
- University of Michigan, Ann Arbor.
- Johns Hopkins University, Baltimore, Maryland.
ORCID-Profile: Monica Yang, Yiwei Yuan, Dinesh Khanna, Zsuzsanna H McMahan, Monique Hinchcliff
Förderung
- NIAMS NIH HHS
- NCATS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Scleroderma Research Foundation
- Dr. Ralph and Marian Falk Medical Research Trust
Zitieren
APA
Yang, M., Goh, V., Lee, J., Espinoza, M., Yuan, Y., Carns, M., Aren, K., Chung, L., Khanna, D., McMahan, Z. H., Agrawal, R., Nelson, L. B., Shah, S. J., Whitfield, M. L., & Hinchcliff, M. (2023). Clinical Phenotypes of Patients With Systemic Sclerosis With Distinct Molecular Signatures in Skin. Arthritis Care & Research, 75(7), 1469-1480. https://doi.org/10.1002/acr.24998
Vancouver
Yang M, Goh V, Lee J, Espinoza M, Yuan Y, Carns M, et al. Clinical Phenotypes of Patients With Systemic Sclerosis With Distinct Molecular Signatures in Skin. Arthritis Care & Research. 2023;75(7):1469-1480. doi:10.1002/acr.24998
BibTeX
@article{Yang2023,
author = {Yang, Monica and Goh, Vivien and Lee, Jungwha and Espinoza, Monica and Yuan, Yiwei and Carns, Mary and Aren, Kathleen and Chung, Lorinda and Khanna, Dinesh and McMahan, Zsuzsanna H and Agrawal, Rishi and Nelson, Lauren Beussink and Shah, Sanjiv J and Whitfield, Michael L and Hinchcliff, Monique},
title = {Clinical Phenotypes of Patients With Systemic Sclerosis With Distinct Molecular Signatures in Skin},
journal = {Arthritis Care & Research},
year = {2023},
volume = {75},
number = {7},
pages = {1469--1480},
doi = {10.1002/acr.24998}
}
EUVIMED